Stefan Grass
Geen lopende functies
Vermogen: 66 695 $ op 31-03-2024
Profiel
Stefan Grass worked as a Medical Officer at CSL Behring AB.
He also served as the Chief Medical & Technology Officer at Bactiguard Holding AB from 2019 to 2020.
Dr. Grass obtained his graduate and doctorate degrees from Karolinska Institutet.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BACTIGUARD HOLDING AB
0.03% | 31-12-2022 | 9 850 ( 0.03% ) | 66 695 $ | 31-03-2024 |
Eerdere bekende functies van Stefan Grass
| Bedrijven | Functie | Einde |
|---|---|---|
CSL Behring AB
 CSL Behring AB Pharmaceuticals: MajorHealth Technology CSL Behring AB develops, manufactures, and markets protein-based therapies in the bleeding disorders, critical care, immunoglobulins, and pulmonary areas. It offers therapies such as plasma-derived and recombinant coagulation factors, immunoglobulins for the treatment of primary immune deficiency, alpha1-proteinase inhibitor for chronic A1-PI augmentation therapy, and C1-INH concentrate. The company was founded in 1904 and is headquartered in Danderyd, Sweden. | Corporate Officer/Principal | - |
| BACTIGUARD HOLDING AB | Chief Tech/Sci/R&D Officer | - |
Opleiding van Stefan Grass
| Karolinska Institutet | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BACTIGUARD HOLDING AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
CSL Behring AB
CSL Behring AB Pharmaceuticals: MajorHealth Technology CSL Behring AB develops, manufactures, and markets protein-based therapies in the bleeding disorders, critical care, immunoglobulins, and pulmonary areas. It offers therapies such as plasma-derived and recombinant coagulation factors, immunoglobulins for the treatment of primary immune deficiency, alpha1-proteinase inhibitor for chronic A1-PI augmentation therapy, and C1-INH concentrate. The company was founded in 1904 and is headquartered in Danderyd, Sweden. | Health Technology |
